Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells
暂无分享,去创建一个
M. Bros | M. Roskamp | S. Grabbe | E. Montermann | Michael Kuske | Marco Vahldieck | A. Dzionek | H. Stege | I. Tubbe | M. Bednarczyk | Carolina Medina-Montano | Frederic Julien Fittler | Christian Langer | Nadine Röhrig | Matthias Bros
[1] G. Alter,et al. Tissues: the unexplored frontier of antibody mediated immunity. , 2021, Current opinion in virology.
[2] H. Hammad,et al. CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01 , 2021, Frontiers in Immunology.
[3] E. Rowan,et al. Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview , 2020, Immunologic Research.
[4] J. Golay,et al. The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs , 2020, Antibodies.
[5] T. Mutis,et al. Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies , 2020, Cancers.
[6] M. Bros,et al. Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy , 2020, Cells.
[7] Joshua A. Jackman,et al. Cloaking Silica Nanoparticles with Functional Protein Coatings for Reduced Complement Activation and Cellular Uptake. , 2020, ACS nano.
[8] Xiqun Jiang,et al. Antibody and antibody fragments for cancer immunotherapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[9] Zhaowu Ma,et al. Dendritic cell biology and its role in tumor immunotherapy , 2020, Journal of Hematology & Oncology.
[10] Xun Sun,et al. Engineering nanoparticulate vaccines for enhancing antigen cross-presentation. , 2020, Current opinion in biotechnology.
[11] D. Dudziak,et al. Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy , 2020, Pharmaceutics.
[12] Ping Wang,et al. Therapeutic Potential of B-1a Cells in COVID-19. , 2020, Shock.
[13] M. I. Tadros,et al. Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers , 2020, International journal of nanomedicine.
[14] S. Acton,et al. Molecular mechanisms of dendritic cell migration in immunity and cancer , 2020, Medical Microbiology and Immunology.
[15] Li Zhao,et al. Polyglycerol Grafting Shields Nanoparticle from Protein Corona Formation to Avoid Macrophage Uptake. , 2020, ACS nano.
[16] Sharan Bobbala,et al. Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets , 2020, Nature Communications.
[17] Zhaolin Hua,et al. The role of B cell antigen presentation in the initiation of CD4+ T cell response , 2020, Immunological reviews.
[18] W. Chan,et al. An analysis of the binding function and structural organization of the protein corona. , 2020, Journal of the American Chemical Society.
[19] M. Jaafari,et al. Liposome Circulation Time is Prolonged by CD47 Coating. , 2020, Protein and peptide letters.
[20] B. Wines,et al. Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs , 2020, Immunology and cell biology.
[21] M. Bros,et al. β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease , 2020, International journal of molecular sciences.
[22] A. Erdei,et al. Utilization of complement receptors in immune cell - microbe interaction. , 2020, FEBS letters.
[23] M. Yoshimoto. The ontogeny of murine B-1a cells , 2019, International Journal of Hematology.
[24] M. Maes,et al. Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses. , 2019, Pharmacological research.
[25] G. Bardi,et al. Natural Polysaccharide Nanomaterials: An Overview of Their Immunological Properties , 2019, International journal of molecular sciences.
[26] E. Groman,et al. Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II. , 2019, Molecular pharmaceutics.
[27] Yongkui Zhang,et al. Protein corona of metal-organic framework nanoparticals: Study on the adsorption behavior of protein and cell interaction. , 2019, International journal of biological macromolecules.
[28] N. Fazilleau,et al. Regulation of B cell responses by distinct populations of CD4 T cells , 2019, Biomedical journal.
[29] R. Noubade,et al. Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity , 2019, Front. Immunol..
[30] Hans-Ulrich Humpf,et al. Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles , 2019, Beilstein journal of nanotechnology.
[31] R. R. Novaes e Brito,et al. B-1 cell response in immunity against parasites , 2019, Parasitology Research.
[32] M. Pallardy,et al. Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: influence of surface properties on dendritic cell activation , 2019, Nanotoxicology.
[33] H. Simon,et al. Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation , 2019, Cell Death & Differentiation.
[34] N. Baumgarth,et al. The Multifaceted B Cell Response to Influenza Virus , 2019, The Journal of Immunology.
[35] T. Vorup-Jensen,et al. Structural Immunology of Complement Receptors 3 and 4 , 2018, Front. Immunol..
[36] S. Tenzer,et al. Protein corona–mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses , 2018, Journal of Allergy and Clinical Immunology.
[37] K. Landfester,et al. The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery , 2018, Front. Immunol..
[38] M. Andersson,et al. Curvature-dependent effects of nanotopography on classical immune complement activation. , 2018, Acta biomaterialia.
[39] G. Arrigoni,et al. C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes. , 2018, ACS nano.
[40] K. Dawson,et al. Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure. , 2018, ACS nano.
[41] M. Kortylewski,et al. The revival of CpG oligonucleotide-based cancer immunotherapies , 2018, Contemporary oncology.
[42] Reinhold Förster,et al. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo. , 2017, Trends in immunology.
[43] K. Toh,et al. Molecularly Imprinted Nanogels Acquire Stealth In Situ by Cloaking Themselves with Native Dysopsonic Proteins. , 2017, Angewandte Chemie.
[44] H. Acha‐Orbea,et al. CD11b regulates the Treg/Th17 balance in murine arthritis via IL‐6 , 2017, European journal of immunology.
[45] V. M. Holers,et al. In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms , 2017, Front. Immunol..
[46] N. Hanagata. CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies , 2017, International journal of nanomedicine.
[47] G. Ferrari,et al. Beyond Viral Neutralization. , 2017, AIDS research and human retroviruses.
[48] S. Seok,et al. GM-CSF Grown Bone Marrow Derived Cells Are Composed of Phenotypically Different Dendritic Cells and Macrophages , 2016, Molecules and cells.
[49] H. Schild,et al. Vaccination with trifunctional nanoparticles that address CD8+ dendritic cells inhibits growth of established melanoma. , 2016, Nanomedicine.
[50] Scott N. Mueller,et al. CD4+ T‐cell help amplifies innate signals for primary CD8+ T‐cell immunity , 2016, Immunological reviews.
[51] S. Kent,et al. Human immune cell targeting of protein nanoparticles--caveospheres. , 2016, Nanoscale.
[52] Justine D Mintern,et al. Targeting dendritic cells: a promising strategy to improve vaccine effectiveness , 2016, Clinical & translational immunology.
[53] J. Vishwanatha,et al. Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy. , 2016, Nanomedicine.
[54] S. Cherry,et al. Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation , 2015, Nature Communications.
[55] Guoquan Zhang,et al. Role of B Cells in Host Defense against Primary Coxiella burnetii Infection , 2015, Infection and Immunity.
[56] Ping Wang,et al. The role of B-1 cells in inflammation , 2015, Immunologic research.
[57] Lubka T. Roumenina,et al. Complement System Part II: Role in Immunity , 2015, Front. Immunol..
[58] C. Solans,et al. Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies. , 2015, Nanoscale.
[59] S. Eberhardt,et al. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. , 2015, AJR. American journal of roentgenology.
[60] M. Carroll,et al. Follicular dendritic cells: dynamic antigen libraries , 2014, Nature Reviews Immunology.
[61] Darren J. Martin,et al. Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. , 2014, ACS nano.
[62] Xiaoling Hu,et al. Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance , 2013, Nature Communications.
[63] F. Broere,et al. Peritoneal cavity B‐1a cells promote peripheral CD4+ T‐cell activation , 2013, European journal of immunology.
[64] I. Tsigelny,et al. Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI. , 2013, ACS nano.
[65] J. Hamerman,et al. β2 integrins inhibit TLR responses by regulating NF‐κB pathway and p38 MAPK activation , 2013, European journal of immunology.
[66] J. Buyon,et al. Complement Receptor 3 Influences Toll-like Receptor 7/8-Dependent Inflammation , 2013, The Journal of Biological Chemistry.
[67] Junling Wang,et al. PU.1 Is Essential for CD11c Expression in CD8+/CD8− Lymphoid and Monocyte-Derived Dendritic Cells during GM-CSF or FLT3L-Induced Differentiation , 2012, PloS one.
[68] I. Tsigelny,et al. Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains. , 2012, Bioconjugate chemistry.
[69] T. Rothstein,et al. A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus , 2011, The Journal of experimental medicine.
[70] A. Salomon,et al. Lectin Site Ligation of CR3 Induces Conformational Changes and Signaling* , 2011, The Journal of Biological Chemistry.
[71] Nan Li,et al. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b , 2010, Nature Immunology.
[72] R. Ludwig. Therapeutic use of heparin beyond anticoagulation. , 2009, Current drug discovery technologies.
[73] J. Prechl,et al. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. , 2009, Molecular immunology.
[74] Heather N. Hayenga,et al. Differential Regulation of Neutrophil CD18 Integrin Function by Di- and Tri-Valent Cations: Manganese vs. Gadolinium , 2008, Annals of Biomedical Engineering.
[75] R. Roozendaal,et al. Complement receptors CD21 and CD35 in humoral immunity , 2007, Immunological reviews.
[76] C. Bode,et al. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. , 2007, Atherosclerosis.
[77] Debra K. Shivers,et al. Complement Receptor 3 Ligation of Dendritic Cells Suppresses Their Stimulatory Capacity1 , 2007, The Journal of Immunology.
[78] D. Vestweber,et al. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. , 2007, Blood.
[79] C. Vauthier,et al. Complement Activation by Core–Shell Poly(isobutylcyanoacrylate)–Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide , 2006, Pharmaceutical Research.
[80] Simon C Watkins,et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. , 2003, Blood.
[81] L. Schwarzfischer,et al. Comparative analysis of integrin expression on monocyte‐derived macrophages and monocyte‐derived dendritic cells , 2000, Immunology.
[82] G. Kelsoe,et al. Antibody response to a T-dependent antigen requires B cell expression of complement receptors , 1996, The Journal of experimental medicine.
[83] N. Cooper,et al. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. , 1994, Journal of immunology.
[84] V. Vetvicka,et al. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions , 1993, Clinical and experimental immunology.
[85] D. Golenbock,et al. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists. , 1991, Journal of immunology.
[86] R. Steinman,et al. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies , 1990, The Journal of experimental medicine.
[87] Jamal S. Lewis,et al. Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis. , 2017, Biomaterials.
[88] Meredith O'Keeffe,et al. Monitoring dendritic cell activation and maturation. , 2013, Methods in molecular biology.
[89] Ying S. Chao,et al. Role of carbohydrate receptors in the macrophage uptake of dextran-coated iron oxide nanoparticles. , 2012, Advances in experimental medicine and biology.
[90] Istvan Toth,et al. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.
[91] M. Büchler,et al. Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo , 2005, Cancer Immunology, Immunotherapy.